Cite
HARVARD Citation
Groeneveldt, C. et al. (2020). Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Journal for immunotherapy of cancer. 8 (2), p. . [Online].